Subthalamic nucleus deep-brain stimulation may have a negative impact on cognition in Parkinson disease patients with GBA mutations

Abstract

Objective: This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease.